Sizhe Yu

Zhejiang Cancer Hospital — China

Medicine · Health Sciences

9h-index315citations21works7.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(7), Lung Cancer Research Studies(5), Cancer, Hypoxia, and Metabolism(4), Cancer Immunotherapy and Biomarkers(3), Autophagy in Disease and Therapy(3)

Publications21 total

High-Dose Aumolertinib for Untreated <i>EGFR</i>-Variant Non–Small Cell Lung Cancer With Brain Metastases
JAMA Oncology·2025· 5 citedOpen Access
Predictive value of circulating tumor DNA detection for long-term survival in patients with advanced lung cancer undergoing chemoimmunotherapy.
Journal of Clinical Oncology·2025
Efficacy and safety of HTMC0435 combination with temozolomide in relapsed extensive-stage small-cell lung cancer (ES-SCLC): A phase Ib/II study.
Journal of Clinical Oncology·2025
Brain radiotherapy combined with camrelizumab and platinum-doublet chemotherapy for previously untreated advanced non-small-cell lung cancer with brain metastases (C-Brain): a multicentre, single-arm, phase 2 trial
The Lancet Oncology·2025· 19 cited
Clinical and Molecular Characteristics Associated With Pleural Metastasis in Advanced Non-Small Cell Lung Cancer
Discovery Medicine·2025Open Access
Cancer-associated fibroblasts promote the progression and chemoresistance of HCC by inducing IGF-1
Cellular Signalling·2024· 19 citedOpen Access
Effectiveness of high-dose third-generation EGFR-tyrosine kinase inhibitors in treating EGFR-mutated non-small cell lung cancer patients with leptomeningeal metastasis
Lung Cancer·2024· 8 cited
Serine/threonine kinase 36 induced epithelial-mesenchymal transition promotes docetaxel resistance in prostate cancer
Scientific Reports·2024· 4 citedOpen Access
Association of Immune-Related Adverse Events and the Efficacy of Anti–PD-(L)1 Monotherapy in Non–Small Cell Lung Cancer: Adjusting for Immortal-Time Bias
Cancer Research and Treatment·2024· 15 citedOpen Access
A molecular approach integrating genomic and DNA methylation profiling for tissue of origin identification in lung-specific cancer of unknown primary
Journal of Translational Medicine·2022· 9 citedOpen Access
Additional file 2 of A molecular approach integrating genomic and DNA methylation profiling for tissue of origin identification in lung-specific cancer of unknown primary
Figshare·2022Open Access
Efficacy of <scp>PD</scp>‐1/<scp>PD‐L1</scp> inhibitors in patients with non‐small cell lung cancer and brain metastases: A real‐world retrospective study in <scp>China</scp>
Thoracic Cancer·2021· 30 citedOpen Access
Role of cancer‑associated fibroblasts in the resistance to antitumor therapy, and their potential therapeutic mechanisms in non‑small cell lung cancer (Review)
Oncology Letters·2021· 31 citedOpen Access
NT157 Inhibits Hepatocellular Carcinoma Growth and Sensitizes Cells to Sorafenib
Research Square (Research Square)·2021Open Access
NT157 Inhibits HCC Migration via Downregulating the STAT3/Jab1 Signaling Pathway
Technology in Cancer Research & Treatment·2021· 7 citedOpen Access
Progress on treatment of MET signaling pathway in non-small cell lung cancer
International Journal of Clinical Oncology·2020· 6 cited
Epithelial–mesenchymal transition induced cancer‐stem‐cell‐like characteristics in hepatocellular carcinoma
Journal of Cellular Physiology·2019· 33 cited
A four-methylated mRNA signature-based risk score system predicts survival in patients with hepatocellular carcinoma
Aging·2019· 37 citedOpen Access
<i>P57</i>‐mediated autophagy promotes the efficacy of <i>EGFR</i> inhibitors in hepatocellular carcinoma
Liver International·2018· 20 cited
Autophagy in the “inflammation-carcinogenesis” pathway of liver and HCC immunotherapy
Cancer Letters·2017· 68 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Kaiyan Chen(9), Hui Guo(8), Hui Li(7), Yun Fan(7), Zhiping Ruan(5), Yanjun Xu(5), Lei Gong(5), Zhiyu Huang(5), François X. Claret(4), Tao Tian(4), Kejun Nan(4), Jia Hou(4), Xiaoqing Yu(4), Hongyang Lu(4), Na Han(4), Qing Li(3), Xuan Liang(3), Jing Li(3), Zhiyu Huang(3), Fajun Xie(3)